gotoper Sign Up Information

November 5-7, 2020
Emory Conference Center Hotel | Atlanta, GA

An increasing number of oncologists are focusing their clinical practices on the treatment of breast cancer, creating a need for specialized education. The School of Breast Oncology®, which has been held annually since 2003, was developed to advance patient care by providing a curriculum-based program focused exclusively on breast cancer clinical management. This intensive 3-day interactive program will provide a comprehensive review of data on the most important aspects of breast cancer biology, diagnostics, prevention, and treatment, with lectures emphasizing clinical implications presented by leading clinical investigators.

Register by April 1st and save 25%* using code SOBO20ESD

Benefits of Attending:

• Participate in dynamic case management discussions
• Discuss the future of breast oncology with Joyce O'Shaughnessy, MD
• Network with hundreds of healthcare professionals interested in breast oncology
• Improve your multidisciplinary care using the latest updates and strategies in breast oncology
• Learn from more than 25 expert faculty leading didactic presentations, panel discussions, and more

Accreditation/Credit Designation
Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC, designates this live activity for AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669.

Saturday, March 21, 2020
MGM National Harbor® | Oxon Hill, MD

Use code SOGO20SD at checkout by to save 35%

Led by world-renowned experts John L. Marshall, MD, and Michael A. Choti, MD, MBA, FACS, this multitrack symposium, now in its fifth year, will provide attendees with the tools needed to personalize care for each one of their patients with gastrointestinal (GI) cancer. The program will include various modules that feature general presentations on important concepts in the field, along with separate side tracks to provide workshops geared toward personalized learning in smaller and more intimate settings. With 3 tracks – medical oncology, surgical and radiation oncology, and case-based SOGO Seminars — the program is designed to match the learning interests of everyone who attends.

Agenda Highlights

• Treating Young Patients With Colon Cancer
• GE-Junction Tumors: Esophageal or Gastric, Does It Matter?
• DEBATE: Has the Sun Set on Radiation Therapy for Locally Resectable, Early Stage PDAC?
•  Treating Early Stage Rectal Cancer After Complete Response Following Preoperative Chemoradiotherapy: Watch and Wait, or Resect?
• Medical Crossfire®: Evolution of Rectal Cancer
• PRRT: When and How
• Medical Crossfire: Role of Circulating Tumor DNA (ctDNA) in Monitoring Gastrointestinal Malignancies

5th Annual School of Gastrointestinal Oncology™ (SOGO®)
Saturday, March 21, 2020
MGM National Harbor®
101 MGM National Avenue
Oxon Hill, MD

gotoper.com/go/SOGO20SD

Program Co-Chairs

Accreditation/Credit Designation
Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 7.25 Contact Hours.

Oncology is changing. The future will be more precise.

InterContinental® New York Barclay | April 17-18, 2020

 At this pan-tumor, interactive symposium, discussions will encompass the latest topics in major solid and liquid tumors. This symposium will cover key malignancies, including lung cancers, breast cancers, gastrointestinal cancers, genitourinary cancers, skin cancers, and hematologic malignancies, and feature keynote lectures focusing on precision medicine.

Agenda Highlights

• Genomics of Response to Immune Checkpoint Therapies for Cancer: Implications for Precision Medicine
• Novel Targets and Precision Medicine for Prostate Cancer    
• DLBCL: How Do Modern Diagnostics Identify High-Risk Diffuse Large B-Cell Lymphoma Subsets and Alter Treatment
• Follicular Lymphoma in 2020: Picking and Rationalizing First-Line Therapy    
• MM: How the MMRF Cohort Can Teach Us the Best Sequence of Therapy
• Predicting Toxicity and Efficacy of CAR T cells
• Genomic Approaches to Immunological Signatures and Their Implications

Program Chair

Andre H. Goy, MD
Professor of Medicine
Georgetown University
Chairman and Executive Director
Chief, Division of Lymphoma
Director, Clinical and Translational Research
John Theurer Cancer Center at UMC
Chief Science Officer
Regional Care Associates
Lydia Pfund Chair for Lymphoma
Seton Hall-Hackensack Meridian School of Medicine
Hackensack, NJ

Benefits of Attending

• Network with your peers and the top minds in precision medicine.
• Learn to better understand genomic approaches to immunological signatures and their implications.
• Update your knowledge of tumor-agnostic clinical studies.
• Implement precision medicine into lung, breast, GI, GU & skin cancer, plus hematologic malignancies.

2nd Annual Precision Medicine Symposium
April 17-18, 2020
InterContinental® New York Barclay
111 E 48th Street, New York, NY 10017
gotoper.com/go/PMC20SD

*Discount only valid for healthcare professionals. Restrictions may apply.

Accreditation/Credit Designation
Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
This activity has been approved for AMA PRA Category 1 Credit™.Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669.
The program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points.

November 5-7, 2020
Emory Conference Center Hotel | Atlanta, GA

Accreditation/Credit Designation
Physicians (CME)
Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 27.25 AMA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses (Contact Hours)
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669 for 27.25 Contact Hours.
Maintenance of Certification (MOC) Points
Medical Oncologists (ABIM)
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 27.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Surgical Oncologists/Surgeons
This activity provides Category I CME and self-assessment credits toward Part 2 of the ABS MOC Program. For more information, please visit www.absurgery.org

Join Us Tonight! - March 23, 2020
8:00 PM  EST

The novel coronavirus that causes COVID-19 infection is rapidly becoming one of the most challenging public health crises in modern history. With more than 200,000 confirmed infections worldwide, including more than 4000 cases in the United States, this virus has the potential to infect individuals of all ages. However, older individuals and patients with underlying health conditions, including cardiovascular disease, diabetes, and pulmonary disorders, seem to be most vulnerable to infection and to developing more severe illness. Patients with cancer must also be considered in this vulnerable and high-risk population.

But how is this pandemic specifically affecting cancer care, and what should you need to know to ensure you are providing the best care to your patients with cancer?

Participate in this live webcast and join the discussion on this fast-moving topic!

Learning Objectives

• Discuss the risk of infection with the novel coronavirus (SARS-CoV-2) and severity of illness with COVID-19 across the populations of patients with hematologic and solid tumor malignancies
• Identify optimal protocols for cancer facilities, in both the inpatient and outpatient settings, to help minimize the risk of coronavirus infection
• Assess strategies to optimize treatment protocols for patients with cancer in light of the current COVID-19 pandemic

Program Co-Chairs

Accreditation/Credit Designation
Physicians'' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians'' Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians'' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Commercial Support
This activity has been developed and funded by Physicians’ Education Resource®, LLC.

Ask  Oncology Experts Your
Critical  Questions about COVID-19''s
Impact on Patient Care

Monday, May 18, 2020
8 PM EDT

COVID-19 has become one of the most challenging health crises in modern history. With over 4 million cases confirmed worldwide, including over 1 million cases in the US (as of May 12, 2020), this virus has the potential to infect people of all ages.  

COVID-19 can cause a range of breathing problems, from mild to critical. Older adults and people who have other health conditions like heart disease, cancer, and diabetes may have more serious symptoms.

The COVID-19 outbreak has significantly changed how patient care is being administered. Face-to-face appointments are essential and telemedicine has become the new normal. There are new best practices to get used to in this new medical landscape, causing many advanced practitioners to learn new ways to communicate with patients.

Join us this Monday to learn from oncology experts who have been making progressive changes to  successfully administer care.

Extraordinary times call for extraordinary caregivers!

"This series breaks down best practices for cancer care during the pandemic, and prepares me for what''s to come." - Week 8 Viewer

Program Faculty

Accreditation/Credit Designation

Physicians'' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians'' Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians'' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Support
This activity is supported by educational grants from Bristol-Myers Squibb; Daiichi Sankyo, Inc.; Novartis Pharmaceuticals Corporation; and Pfizer Inc.

Thursday, March 19, 2020
8:00 PM – 9:30 PM EST

This live video webcast will explore current trends in prognostic scoring, molecular diagnostics, and guideline-based management of myeloproliferative neoplasms (MPNs). Learn about the  most appropriate treatments based upon patient and tumor characteristics, and hear the experts apply novel management strategies to real-world scenarios. The interactive forum will allow you to ask specific questions to optimize treatment strategies and manage adverse events for your patients.

Agenda Hot Topics

• The progressing utility of interferons
• High-risk mutations and their impact for treatment decision making
• Novel JAK inhibitors on the horizon
• Double and triple therapy combinations in clinical development

Program Chair

Accreditation/Credit Designation
Physicians'' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians'' Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support
This activity is supported by educational grants from Celgene Corporation; Incyte Corporation; and PharmaEssentia USA.

Thursday, March 19, 2020
8:00 PM – 9:30 PM EST

This live video webcast will explore current trends in prognostic scoring, molecular diagnostics, and guideline-based management of myeloproliferative neoplasms (MPNs). Learn about the  most appropriate treatments based upon patient and tumor characteristics, and hear the experts apply novel management strategies to real-world scenarios. The interactive forum will allow you to ask specific questions to optimize treatment strategies and manage adverse events for your patients.

Agenda Hot Topics

• The progressing utility of interferons
• High-risk mutations and their impact for treatment decision making
• Novel JAK inhibitors on the horizon
• Double and triple therapy combinations in clinical development

Program Chair

Accreditation/Credit Designation
Physicians'' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians'' Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support
This activity is supported by educational grants from Celgene Corporation; Incyte Corporation; and PharmaEssentia USA.

Beat the heat this summer with virtual CME/CE from PER®

During this time of transition, the summer meetings may look different, but PER®’s commitment to world-class CME/CE remains the same. Our proven live-stream platform will deliver all of the legacy conferences you and your colleagues have turned to for more than 20 years — with a few new additions to meet the evolving needs of the PER® community. You can be assured that each event will deliver the same level of impactful education and unrivaled faculty access as ever.

Learn more about our upcoming events for July, and register online today.

July 2020

Complimentary live webcasts on the latest updates from the Annual Oncology Meeting at convenient dates and times. Join industry experts as they discuss recent advancements in oncology care. 

Monday, July 8

This webcast is part of a regularly occurring series, held each Monday at 8 PM EDT, which features new experts each week. How is this pandemic specifically affecting cancer care, and what do clinicians need to know today to ensure they are providing the best care to their patients with cancer?

Tuesday, July 7

During this Medical Crossfire®, expert faculty specializing in pulmonology, rheumatology, and diagnostic radiology will share multidisciplinary perspectives and opposing views on making an accurate diagnosis and considering treatment with antifibrotics that can delay disease progression. As part of this webcast, faculty will review ILDs with progressive fibrosing phenotypes with their unique patterns of fibrosis, and will also discuss the role and risks of advanced diagnostic procedures.

Tuesday, July 7

Medical Crossfire®: Perfecting the Diagnosis and Treatment of EGPA: Patient Perspectives and Expert Insights will highlight current unmet medical needs and the most recent advances in the management of eosinophilic granulomatosis with polyangiitis (EGPA). This program has been transformed into an interactive webcast which features a panel discussion of expert faculty specializing in the care of patients diagnosed with EGPA.

Tuesday, June 16

This live webcast will be presented by experts in NSCLC to discuss testing strategies for HER2 alterations in a clinically applicable manner. The expert panel will discuss current and emerging treatment options for HER2 alteration-positive NSCLC.

Saturday, July 11

PER®, presents the 4th Annual Live Medical Crossfire®: Hematologic Malignancies—a 1-day, highly engaging conference designed to explore the most pressing clinical issues in the field of hematologic malignancies through live, interactive panel discussions with renowned experts. This live-stream meeting will contrast viewpoints of key thought leaders from across the country and the world regarding current standards of practice and emerging clinical data for liquid tumors.

Wednesday, July 15

This live webcast will be presented by experts in SCLC and will begin with a rapid overview of clinical data leading to recent approvals, as well as emerging approaches and management of treatment-related adverse events. The heart of this program includes several case-based tumor board discussions addressing the application of new agents in a variety of clinical settings in SCLC.

EAST: Friday-Saturday, July 17-18
WEST: Friday-Saturday, July 31- August 1

The 19th Annual International Congress on the Future of Breast Cancer® will update clinicians on recent advances in the treatment of breast cancer, from breakthroughs in the lab to changes in treatment paradigms. Join Program Chair Joyce A. O’Shaughnessy, MD, and Sara Hurvitz, MD, and other faculty as they share practical implications of emerging data for patient care in the clinic. This virtual conference provides a unique opportunity for medical, surgical, and radiation oncologists to increase knowledge, apply new data to practice, and, ultimately, improve patient care.

July 23-25

The 21st Annual International Lung Cancer Congress® will provide current, practical information on the management of lung cancer, as well as a look at the novel agents and strategies that may potentially shape the future of lung cancer therapy. Throughout this interactive virtual conference, leading international and national experts will provide perspectives on how to apply the latest data on targeted agents, immunotherapy, surgery, and radiation oncology in the clinic.

July 31 - August 1

Rapid advancements in the field of oncology nursing are raising the bar for the care of your patients, and the 4th Annual School of Nursing Oncology™ is an ideal setting to learn about the latest updates in a practical and applicable way. Join us for this 2-day virtual conference to explore the numerous advancements in the pharmacologic treatment of cancer, as well as complementary therapies to help mitigate disease symptoms and potential treatment-related adverse events that are emerging at a rapid pace.

Saturday, March 21, 2020
MGM National Harbor® | Oxon Hill, MD

Use code SOGO20SD at checkout by to save 35%

Led by world-renowned experts John L. Marshall, MD, and Michael A. Choti, MD, MBA, FACS, this multitrack symposium, now in its fifth year, will provide attendees with the tools needed to personalize care for each one of their patients with gastrointestinal (GI) cancer. The program will include various modules that feature general presentations on important concepts in the field, along with separate side tracks to provide workshops geared toward personalized learning in smaller and more intimate settings. With 3 tracks – medical oncology, surgical and radiation oncology, and case-based SOGO Seminars — the program is designed to match the learning interests of everyone who attends.

Agenda Highlights

• Treating Young Patients With Colon Cancer
• GE-Junction Tumors: Esophageal or Gastric, Does It Matter?
• DEBATE: Has the Sun Set on Radiation Therapy for Locally Resectable, Early Stage PDAC?
•  Treating Early Stage Rectal Cancer After Complete Response Following Preoperative Chemoradiotherapy: Watch and Wait, or Resect?
• Medical Crossfire®: Evolution of Rectal Cancer
• PRRT: When and How
• Medical Crossfire: Role of Circulating Tumor DNA (ctDNA) in Monitoring Gastrointestinal Malignancies

5th Annual School of Gastrointestinal Oncology™ (SOGO®)
Saturday, March 21, 2020
MGM National Harbor®
101 MGM National Avenue
Oxon Hill, MD

gotoper.com/go/SOGO20SD

Program Co-Chairs

Accreditation/Credit Designation
Physicians'' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians'' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 7.25 Contact Hours.

Acknowledgment of Commercial Support
This activity is supported by educational grants from AstraZeneca; Daiichi Sankyo, Inc.; Genentech, Inc.; and Taiho Oncology, Inc.

Join Us Tonight! - March 23, 2020
8:00 PM  EST

The novel coronavirus that causes COVID-19 infection is rapidly becoming one of the most challenging public health crises in modern history. With more than 200,000 confirmed infections worldwide, including more than 4000 cases in the United States, this virus has the potential to infect individuals of all ages. However, older individuals and patients with underlying health conditions, including cardiovascular disease, diabetes, and pulmonary disorders, seem to be most vulnerable to infection and to developing more severe illness. Patients with cancer must also be considered in this vulnerable and high-risk population.

But how is this pandemic specifically affecting cancer care, and what should you need to know to ensure you are providing the best care to your patients with cancer?

Participate in this live webcast and join the discussion on this fast-moving topic!

Learning Objectives

• Discuss the risk of infection with the novel coronavirus (SARS-CoV-2) and severity of illness with COVID-19 across the populations of patients with hematologic and solid tumor malignancies
• Identify optimal protocols for cancer facilities, in both the inpatient and outpatient settings, to help minimize the risk of coronavirus infection
• Assess strategies to optimize treatment protocols for patients with cancer in light of the current COVID-19 pandemic

Program Co-Chairs

Accreditation/Credit Designation
Physicians'' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians'' Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians'' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Commercial Support
This activity has been developed and funded by Physicians’ Education Resource®, LLC.

Join PER® for a high-impact,
all-virtual year of
CME conferences

WEBCAST HAS BEEN RESCHEDULED
New Date: Wednesday, May 20, 2020
8:00 PM – 9:30 PM EST

Because of travel bans affecting the faculty''s journey to our studio, we have made the decision to move the date of the live webcast from this Thursday to May 20th, 2020. We hope that you are still able to join us. Your registration will not be affected by this change of date. Please stay tuned for any further updates.

This live video webcast will explore current trends in prognostic scoring, molecular diagnostics, and guideline-based management of myeloproliferative neoplasms (MPNs). Learn about the  most appropriate treatments based upon patient and tumor characteristics, and hear the experts apply novel management strategies to real-world scenarios. The interactive forum will allow you to ask specific questions to optimize treatment strategies and manage adverse events for your patients.

Agenda Hot Topics

• The progressing utility of interferons
• High-risk mutations and their impact for treatment decision making
• Novel JAK inhibitors on the horizon
• Double and triple therapy combinations in clinical development

Program Chair

Accreditation/Credit Designation
Physicians'' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians'' Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.5 Contact Hours.

Acknowledgment of Commercial Support
This activity is supported by educational grants from Celgene Corporation; Incyte Corporation; and PharmaEssentia USA.

Monday, March 23, 2020
8:00 PM  EST

The novel coronavirus that causes COVID-19 infection is rapidly becoming one of the most challenging public health crises in modern history. With more than 200,000 confirmed infections worldwide, including more than 4000 cases in the United States, this virus has the potential to infect individuals of all ages. However, older individuals and patients with underlying health conditions, including cardiovascular disease, diabetes, and pulmonary disorders, seem to be most vulnerable to infection and to developing more severe illness. Patients with cancer must also be considered in this vulnerable and high-risk population.

But how is this pandemic specifically affecting cancer care, and what should you need to know to ensure you are providing the best care to your patients with cancer?

Participate in this live webcast and join the discussion on this fast-moving topic!

Learning Objectives

• Discuss the risk of infection with the novel coronavirus (SARS-CoV-2) and severity of illness with COVID-19 across the populations of patients with hematologic and solid tumor malignancies
• Identify optimal protocols for cancer facilities, in both the inpatient and outpatient settings, to help minimize the risk of coronavirus infection
• Assess strategies to optimize treatment protocols for patients with cancer in light of the current COVID-19 pandemic

Program Co-Chairs

Accreditation/Credit Designation
Physicians'' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians'' Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians'' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Commercial Support
This activity has been developed and funded by Physicians’ Education Resource®, LLC.

Taking debates to the next level.

Call (732) 552-5818 or email Phil Talamo at ptalamo@gotoper.com 

Oncology Education Team
Phil Talamo, CHCP, President
ptalamo@gotoper.com | (732) 552-5818

Kirby Beneville, Vice President, Educational Strategy
kbeneville@gotoper.com | (214) 906-6183

Stephanie Neumann, Associate Director, Educational Strategy
sneumann@gotoper.com | (732) 239-2863

Janvi Sharma, Manager, Educational Strategy
jsharma@gotoper.com | (609) 325-4847

Alex Kinsey, Associate, Educational Strategy
akinsey@gotoper.com | (609) 212-3140
 

Hello Oliver,

PER® is committed to delivering you a seamless learning experience. We''re in the process of upgrading our email delivery platform, and the domains from which you receive our emails will soon be changing.

To ensure you continue receiving our emails, please add our new domain email.gotoper.com to your address book/safe senders list. If you are receiving emails at your corporate email address, you may need to contact your IT department to whitelist our new domain.

During our transition period, please note you may still receive the following emails from our current domains:

CME/CE Activity Emails
education@gotoper.com

Informational Emails
info@gotoper.com
 

Sincerely,
Physicians’ Education Resource®, LLC

Saturday, November 7, 2020

Faculty:

UPCOMING VIRTUAL CME/CE WEBCASTS AND CONFERENCES

During this time of transition, our conferences may look different, but PER®’s commitment to world-class CME/CE remains the same. Our proven live-stream platform will deliver all of the legacy conferences you and your colleagues have turned to for more than 20 years — with a few new additions to meet the evolving needs of the PER® community. You can be assured that each event will deliver the same level of impactful education and unrivaled faculty access as ever.

Learn more about our upcoming events for August and September, and register online today.

Thursday, August 13

During this highly interactive, game-style symposium, the audience will be encouraged to examine "mystery" cases, look for clues from the clinical history and presentation, evaluate radiologic imaging and other diagnostic test results, and ultimately uncover the correct diagnosis. Expert faculty will then reveal the underlying disease and review therapeutic options. To learn more click here.

Friday, August 14

This live video webcast will unearth key clinical challenges and best practices in the management of multiple tumor types with next-generation sequencing (NGS) during a facilitated discussion between 2 medical oncologists, a pathologist, and a community oncologist. To learn more click here.

Tuesday, August 25
Tuesday, September 1
Tuesday, September 8
Tuesday, September 15
Tuesday, September 22

The risk of hypoglycemia is a critical limiting factor in glycemic management of individuals with diabetes. Patients are often unaware of the autonomic warning symptoms and diverse causes of hypoglycemia, highlighting a serious need for individualized patient education and multifactorial intervention. In this series of webcasts, expert faculty will review key resources and current guidelines/standards of care to facilitate identification and management of patients at risk of hypoglycemia. To learn more click here.

Saturday, September 12

The 4th Annual New York Cardio-Endo-Renal Collaborative (NY CERC) will focus on strategic and novel approaches to management of integrated cardiometabolic diseases and deliver state-of-the-art clinical updates and strategies aimed at the intersection of metabolic disease and CVD prevention and management. To learn more click here.

Saturday, September 12

The 3rd Annual Advanced Practice Collaborative is a live video broadcast that quickly delivers the latest advances in primary care. Join us as we dive into what you need to know now in clinical topics, including dermatology, diabetes, respiratory illnesses, and rheumatology. To learn more click here.

Friday-Saturday, September 25-26

At this pan-tumor, interactive symposium, discussions will encompass the latest topics in major solid and liquid tumors. This meeting will cover key malignancies, including lung cancers, breast cancers, gastrointestinal cancers, genitourinary cancers, skin cancers, and hematologic malignancies, and feature keynote lectures focusing on precision medicine. High-impact sessions will focus on practical takeaways regarding the latest updates in next-generation sequencing, liquid biopsy, and cytogenetic testing. To learn more click here.

Friday-Saturday, September 25-26

The 2nd Annual International Congress on the Future of Neurology® will present the most recent advancements in neurologic disorders. Faculty will provide their knowledge and expertise for integrating new therapies into clinical practice and will talk about emerging clinical data in 8 core areas. To learn more click here.

Our Second Webcast in Our Series About What Oncologists Need to Know About COVID-19

Monday, March 30, 2020
8:00 PM  EST

The novel coronavirus that causes COVID-19 infection is rapidly becoming one of the most challenging public health crises in modern history. With hundreds of thousands of cases confirmed worldwide, including more than 50,000 cases in the United States (as of 3/25/20), this virus has the potential to infect individuals of all ages. However, older individuals and patients with underlying health conditions, including cardiovascular disease, diabetes, and pulmonary disorders, seem to be the most vulnerable to infection and to developing more severe illness. Your patients with cancer must also be considered in this vulnerable and high-risk population.

But how is this pandemic specifically affecting cancer care, and what do clinicians need to know today to ensure they are providing the best care to their patients with cancer?

On March 23, 2020, 4 experts in cancer care came together to discuss some of the most pressing issues regarding caring for patients with cancer during this pandemic. This initial webcast was so impactful that PER® has decided to transform this into a regularly occurring series, held each Monday evening at 8 PM ET, and featuring new experts each week.

Participate in this ongoing live webcast series and join the discussion on this fast-moving topic.

Learning Objectives

• Discuss the risk of infection with the novel coronavirus (SARS-CoV-2) and severity of illness with COVID-19 across the populations of patients with hematologic and solid tumor malignancies
• Identify optimal protocols for cancer facilities, in both the inpatient and outpatient settings, to help minimize the risk of coronavirus infection
• Assess strategies to optimize treatment protocols for patients with cancer in light of the current COVID-19 pandemic

Program Chair

Accreditation/Credit Designation
Physicians'' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Physicians'' Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians'' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hour.

Acknowledgment of Commercial Support
This activity has been developed and funded by Physicians’ Education Resource®, LLC.

In accordance with ACCME Guidelines, PER® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Disclosures: Speaker’s Bureau: Genomic Health, Inc. and Pacira, Inc.
The staff of Physicians’ Education Resource®, LLC (PER®), have no relevant financial relationships with commercial interests to disclose.

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a health care professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

REGISTER TODAY FOR PER''S JUNE CME/CE 
INTERACTIVE, WEBCASTS

Summer plans look a little different this year, but you can still count on PER® to deliver the same level of high-impact CME/CE conferences that you, and other healthcare professionals, have trusted for more than 20 years. We’ve transformed our annual meetings into interactive virtual events that provide critical information and unparalleled access to expert faculty.  Learn more about our upcoming webcasts for this June.

June 2020